HealthQuill
AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key goal in late-stage trials, the company announced.
Drugs Medical Pharma

AbbVie’s late-stage experimental drug reduces menstrual migraine days

HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key.

Read More
A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a major reversal of previous progress toward the elimination of the disease, according to an editorial in the International Journal of Infectious Diseases.
Drugs Health Opinion

Bangladesh’s measles outbreak an ‘early warning signal’: IJID says

HQ Team September 11, 2026: A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a.

Read More
A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses high-intensity sound waves to break down targeted diseased tissue without incisions, heat, or trauma, enabling the body to heal itself naturally.
Drugs Medical Pharma

US-based start-up developing medical device to replace surgical incision

HQ Team September 10, 2026: A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses.

Read More
Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced.
Drugs Medical Pharma

Novartis’s neuromuscular experimental drug fails to meet targets

HQ Team September 9, 2026: Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced. The.

Read More
The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization, has released 70,000 doses of its experimental Ervebo vaccine to the Democratic Republic of the Congo to assess its effectiveness in combating the Bundibugyo Ebola virus disease.
Drugs Health Research

ICG ships vaccines to Congo to test feasibility in Bundibugyo Ebola

HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,.

Read More
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Pharma

Moderna, Merck’s personalised mRNA vaccine clears Phase 3 in melanoma

HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after.

Read More
flight attendants
Health

Aircrew face highest radiation-related cancer risk among all US jobs: Study

HQ Team August 20, 2026: Nearly 7% of deaths among U.S. flight attendants and pilots are linked to radiation-related cancers — the highest.

Read More
In conflict-ridden Gaza, just 3% of cropland remains usable as Israeli troops pound the region with air strikes and shelling, limiting access to agricultural land and putting pressure on food security, according to the United Nations' FAO.
Climate Health Research

Cropland usage plummets in war-torn Gaza Strip, 3% usable: FAO

HQ Team August 19, 2026: In conflict-ridden Gaza, just 3% of cropland remains usable to grow food as Israeli troops pound the region.

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.

Read More
Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine that may induce an immune response to malaria.
Health

Dundee Lab’s drug shows promise as a single-dose cure for malaria disease

HQ Team August 18, 2026: A malaria drug candidate developed by a University of Dundee lab has cleared an early human trial, raising.

Read More